Page last updated: 2024-12-08
norlorcainide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
norlorcainide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 162188 |
SCHEMBL ID | 11447659 |
MeSH ID | M0098067 |
Synonyms (10)
Synonym |
---|
norlorcainide |
63260-75-3 |
n-(4-chlorophenyl)-2-phenyl-n-piperidin-4-ylacetamide |
einecs 264-052-8 |
n-(4-chlorophenyl)-n-(4-piperidinyl)benzeneacetamide |
SCHEMBL11447659 |
benzeneacetamide, n-(4-chlorophenyl)-n-4-piperidinyl- |
n-(4-chlorophenyl)-2-phenyl-n-(4-piperidinyl)acetamide # |
DTXSID30979316 |
n-(4-chlorophenyl)-2-phenyl-n-(piperidin-4-yl)acetamide |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (11.11%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |